4-hydroxy Nonenal
(Synonyms: 4-羟基壬烯醛,4-HNE) 目录号 : GC42410
4-羟基壬烯醛（4-hydroxy Nonenal，4-HNE）是一种脂质过氧化（LPO）产物，是一种α，β不饱和羟基烯醛，由ω-6多不饱和脂肪酸氧化形成，它是一种无色油。
Cas No.:75899-68-2
Sample solution is provided at 25 µL, 10mM.
4-Hydroxy Nonenal (4-HNE) is a product of lipid peroxidation (LPO), an α,β-unsaturated hydroxyalkenal formed from the oxidation of ω-6 polyunsaturated fatty acids, it is a colorless oil[1]. 4-Hydroxynonenal is considered a biomarker of oxidative stress and acts as a secondary signaling molecule to regulate many cell signaling pathways[2]. 4-Hydroxynonenal is electrophilic and highly reactive and can form 4-HNE-protein adducts with proteins, either through Michael addition reactions or by forming Schiff bases[3]. 4-Hydroxynonenal has biological activities such as cytotoxicity and genotoxicity and is widely used to study diseases related to oxidative stress, including cardiovascular diseases and neurodegenerative diseases [4].
In vitro, 4-hydroxy Nonenal (0-40μM) treatment of human hepatocellular carcinoma HepG2 cells for 2 h induced ASK1-SEK1-JNK caspase-3 activation and apoptosis, induced death domain-associated protein (Daxx) translocation, activated heat shock factor 1 (HSF1) and increased nuclear accumulation, and upregulated heat shock protein 70 (Hsp70) levels[5]. 4-hydroxy Nonenal (1-100μM) treatment of human osteosarcoma HOS cells for 48 h induced apoptosis in a concentration-dependent manner and inhibited cell proliferation and differentiation [6].
In vivo, 4-hydroxy Nonenal (4 mg/kg) was intravenously injected into mice with cardiac ischemia/reperfusion injury, activated the Nrf2 transcription factor in the heart and increased the content of glutathione (GSH) in the myocardium, promoted the functional recovery of the left ventricle, but had no cardioprotective effect on Nrf2 knockout mice[7]. Oral administration of 4-hydroxy Nonenal (12.5 mg/kg) to SD rats for 28 days caused hepatotoxicity and nephrotoxicity, leading to the accumulation of hyaline masses in the renal tubules and degeneration of tubular epithelial cells[8].
References:
[1] Poli G, Schaur R J, Siems W G, et al. 4‐Hydroxynonenal: A membrane lipid oxidation product of medicinal interest[J]. Medicinal research reviews, 2008, 28(4): 569-631.
[2]Sonowal H, Ramana K V. 4-Hydroxy-trans-2-nonenal in the regulation of anti-oxidative and pro-inflammatory signaling pathways[J]. Oxidative medicine and cellular longevity, 2019, 2019.
[3]Milkovic L, Zarkovic N, Marusic Z, et al. The 4-Hydroxynonenal–Protein Adducts and Their Biological Relevance: Are Some Proteins Preferred Targets?[J]. Antioxidants, 2023, 12(4): 856.
[4]Shoeb M, H Ansari N, K Srivastava S, et al. 4-Hydroxynonenal in the pathogenesis and progression of human diseases[J]. Current medicinal chemistry, 2014, 21(2): 230-237.
[5]Chaudhary P, Sharma R, Sharma A, et al. Mechanisms of 4-hydroxy-2-nonenal induced pro-and anti-apoptotic signaling[J]. Biochemistry, 2010, 49(29): 6263-6275.
[6]Sunjic S B, Cipak A, Rabuzin F, et al. The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells[J]. Biofactors, 2005, 24(1‐4): 141-148.
[7]Zhang Y, Sano M, Shinmura K, et al. 4-Hydroxy-2-nonenal protects against cardiac ischemia–reperfusion injury via the Nrf2-dependent pathway[J]. Journal of molecular and cellular cardiology, 2010, 49(4): 576-586.
[8]Kang S C, Kim H W, Kim K B, et al. Hepatotoxicity and nephrotoxicity produced by 4-hydroxy-2-nonenal (4-HNE) following 4-week oral administration to Sprague-Dawley rats[J]. Journal of Toxicology and Environmental Health, Part A, 2011, 74(12): 779-789.
4-羟基壬烯醛（4-hydroxy Nonenal，4-HNE）是一种脂质过氧化（LPO）产物，是一种α，β不饱和羟基烯醛，由ω-6多不饱和脂肪酸氧化形成，它是一种无色油[1]。 4-hydroxy Nonenal被认为是氧化应激的生物标志物，作为次级信号分子来调节许多细胞信号传导途径[2]。4-hydroxy Nonenal具有亲电性和高反应性，可以与蛋白质形成 4-HNE-蛋白质加合物，通过迈克尔加成反应或通过形成席夫碱连接到蛋白质上[3]。4-hydroxy Nonenal具有细胞毒性和遗传毒性等生物活性，广泛用于研究氧化应激相关的疾病，包括心血管疾病和神经退行性疾病等[4]。
在体外，4-hydroxy Nonenal（0-40 μM）处理人肝癌HepG2细胞2 h，诱导了 ASK1-SEK1-JNK caspase-3的激活和细胞凋亡，还诱导了死亡结构域相关蛋白（Daxx）易位，激活了热休克因子1（HSF1）并增加核积累，上调了热休克蛋白70（Hsp70）水平[5]。4-hydroxy Nonenal（1-100 μM）处理人骨肉瘤HOS细胞48 h，以浓度依赖性方式引起细胞凋亡，抑制细胞的增殖和分化[6]。
在体内，4-hydroxy Nonenal（4 mg/kg）通过静脉注射治疗心脏缺血/再灌注损伤小鼠，激活了心脏中的Nrf2转录因子并增加心肌内谷胱甘肽（GSH）含量，促进了左心室的功能恢复，但是对Nrf2敲除小鼠没有心脏保护作用[7]。4-hydroxy Nonenal（12.5 mg/kg）通过口服饲喂SD大鼠28天，会产生肝毒性和肾毒性，导致肾小管内有透明小体积聚和肾小管上皮细胞变性[8]。
Cell experiment [1]: | |
Cell lines | HepG2 cells |
Preparation method | HepG2 cells were treated with 0, 20, and 40 μM 4-hydroxy Nonenal for 2 h followed by the addition of in situ caspase marker and fixation. |
Reaction Conditions | 0, 20, 40 μM ; 2 h |
Applications | 4-hydroxy Nonenal causes the activation of ASK1-SEK1-JNK caspase-3. |
Animal experiment [2]: | |
Animal models | Nrf2-knockout mice、Nrf2-wildtype mice |
Preparation method | Hearts were excised rapidly from heparinized mice, perfused with modifiedKrebs–Henseleit buffer, and gassed with 95% O2 and 5% CO2 at 37°C. Coronary perfusion pressure was maintained at 90 mm Hg. A plastic catheter with a polyethylene balloon was inserted into the left ventricle through the left atrium. Before the induction of ischemia, the left ventricular end-diastolic pressure was adjusted to 10 mm Hg by filling the balloon with water. mice were injected with either 4 mg/kg 4-hydroxy Nonenal or vehicle (50 μlof saline) via the retro-orbital vein. |
Dosage form | 4 mg/kg; i.p. |
Applications | 4-hydroxy Nonenal activated Nrf2 in the heart and increased the intramyocardial GSH content, and consequently improved the functional recovery of the left ventricle following ischemia–reperfusion in Langendorff-perfused hearts. |
References: [1]Chaudhary P, Sharma R, Sharma A, et al. Mechanisms of 4-hydroxy-2-nonenal induced pro-and anti-apoptotic signaling[J]. Biochemistry, 2010, 49(29): 6263-6275. [2] Zhang Y, Sano M, Shinmura K, et al. 4-Hydroxy-2-nonenal protects against cardiac ischemia–reperfusion injury via the Nrf2-dependent pathway[J]. Journal of molecular and cellular cardiology, 2010, 49(4): 576-586. | |
| Cas No. | 75899-68-2 | SDF | |
| 别名 | 4-羟基壬烯醛,4-HNE | ||
| 化学名 | (±)-4-hydroxy-2E-nonenal | ||
| Canonical SMILES | CCCCCC(O)\C=C\C=O | ||
| 分子式 | C9H16O2 | 分子量 | 156.2 |
| 溶解度 | 50mg/mL in DMSO, 50mg/mL in DMF, 50mg/mL Ethanol | 储存条件 | -20°C, protect from light. |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 6.402 mL | 32.0102 mL | 64.0205 mL |
| 5 mM | 1.2804 mL | 6.402 mL | 12.8041 mL |
| 10 mM | 0.6402 mL | 3.201 mL | 6.402 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >97.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet